
Spero Therapeutics, Inc.
SPROHealthcare|Biotechnology|US
$1.03
+0.01 (+0.98%)
Tangible Book / Share
$0.76
Graham Number
$1.48
Cash / Share
$0.88
Next Earnings Report
Nov 12, 2026
EPS est. -$0.47
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Aug 28, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2026 · GlobeNewsWire
Spero Therapeutics to Present at Investor Conferences in November
Nov 2, 2026 · GlobeNewsWire
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Oct 26, 2026 · GlobeNewsWire
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Oct 15, 2026 · GlobeNewsWire
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026 · GlobeNewsWire
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 3, 2026 · GlobeNewsWire
Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 2, 2026 · GlobeNewsWire
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
Aug 12, 2026 · GlobeNewsWire
SEC Filings (43)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 28, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Oct 27, 2026 | 8-K | Material event | DocumentIndex |
| Sep 10, 2026 | EFFECT | DocumentIndex | |
| Aug 28, 2026 | 8-K | Material event | DocumentIndex |
| Aug 28, 2026 | S-3 | Shelf registration | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 14, 2026 | 8-K | Material event | DocumentIndex |
| Jun 25, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 22, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| Apr 27, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 27, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 13, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | 10-K | Annual report | DocumentIndex |
| Jan 30, 2026 | 8-K | Material event | DocumentIndex |
| Dec 19, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2025 | 8-K | Material event | DocumentIndex |
| Jun 18, 2025 | 8-K | Material event | DocumentIndex |
| May 28, 2025 | 8-K | Material event | DocumentIndex |
| May 13, 2025 | 8-K | Material event | DocumentIndex |
| May 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Apr 28, 2025 | ARS | Annual report to holders | DocumentIndex |
| Apr 28, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 28, 2025 | 8-K | Material event | DocumentIndex |
| Mar 28, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 27, 2025 | 8-K | Material event | DocumentIndex |
| Mar 27, 2025 | 10-K | Annual report | DocumentIndex |
| Feb 28, 2025 | 8-K | Material event | DocumentIndex |
| Jan 10, 2025 | 8-K | Material event | DocumentIndex |